Literature DB >> 26926001

Proconvulsant effects of antidepressants - What is the current evidence?

Cecilie Johannessen Landmark1, Oliver Henning2, Svein I Johannessen3.   

Abstract

Antidepressant drugs may have proconvulsant effects. Psychiatric comorbidity in epilepsy is common. Prescribers might be reluctant to initiate treatment with antidepressants in fear of seizure aggravation. The purpose of this review was to focus upon the current evidence for proconvulsant effects of antidepressants and possible clinical implications. Most antidepressants are regarded as safe and may be used in patients with epilepsy, such as the newer serotonin and/or noradrenaline reuptake inhibitors. Four older drugs should, however, be avoided or used with caution; amoxapine, bupropion, clomipramine and maprotiline. Proconvulsant effects are concentration-related. Optimization of drug treatment includes considerations of pharmacokinetic variability to avoid high serum concentrations of the most proconvulsant antidepressants. The risk of seizures is regarded as small and should, therefore, not hamper the pharmacological treatment of depression in people with epilepsy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antidepressant drugs; Drug safety; Proconvulsant; Seizures

Mesh:

Substances:

Year:  2016        PMID: 26926001     DOI: 10.1016/j.yebeh.2016.01.029

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  8 in total

1.  Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IV.

Authors:  Kristin Marie Knudsen-Baas; Tom Børge Johannesen; Tor Åge Myklebust; Jan Harald Aarseth; Jone Furlund Owe; Nils Erik Gilhus; Anette Margrethe Storstein
Journal:  J Neurooncol       Date:  2018-11-23       Impact factor: 4.130

2.  Management of Systemic Medical Emergencies Associated with Psychotropic Medications.

Authors:  Sandeep Grover; Siddharth Sarkar; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2022-03-23       Impact factor: 2.983

Review 3.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

4.  Systematic integration of biomedical knowledge prioritizes drugs for repurposing.

Authors:  Daniel Scott Himmelstein; Antoine Lizee; Christine Hessler; Leo Brueggeman; Sabrina L Chen; Dexter Hadley; Ari Green; Pouya Khankhanian; Sergio E Baranzini
Journal:  Elife       Date:  2017-09-22       Impact factor: 8.140

5.  Antidepressent Effect of Two New Benzyl Derivatives from Wild Strawberry Fragaria vesca var. nubicola Lindl. ex Hook.f.

Authors:  Sadia Naz; Umar Farooq; Ajmal Khan; Haroon Khan; Nasiara Karim; Rizwana Sarwar; Javid Hussain; Abdur Rauf
Journal:  Front Pharmacol       Date:  2017-07-25       Impact factor: 5.810

Review 6.  Psychopharmacology of COVID-19.

Authors:  Melanie Bilbul; Patricia Paparone; Anna M Kim; Shruti Mutalik; Carrie L Ernst
Journal:  Psychosomatics       Date:  2020-05-18       Impact factor: 2.386

Review 7.  Neuroanatomy and function of human sexual behavior: A neglected or unknown issue?

Authors:  Rocco S Calabrò; Alberto Cacciola; Daniele Bruschetta; Demetrio Milardi; Fabrizio Quattrini; Francesca Sciarrone; Gianluca la Rosa; Placido Bramanti; Giuseppe Anastasi
Journal:  Brain Behav       Date:  2019-09-30       Impact factor: 2.708

8.  Chronically altered NMDAR signaling in epilepsy mediates comorbid depression.

Authors:  Mohammad Amin Sadeghi; Sara Hemmati; Sina Mohammadi; Hasan Yousefi-Manesh; Ali Vafaei; Meysam Zare; Ahmad Reza Dehpour
Journal:  Acta Neuropathol Commun       Date:  2021-03-24       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.